| Literature DB >> 28749735 |
Adair L Borges1, Alan R Davidson2, Joseph Bondy-Denomy1.
Abstract
Bacteria and archaea use CRISPR-Cas adaptive immune systems to defend themselves from infection by bacteriophages (phages). These RNA-guided nucleases are powerful weapons in the fight against foreign DNA, such as phages and plasmids, as well as a revolutionary gene editing tool. Phages are not passive bystanders in their interactions with CRISPR-Cas systems, however; recent discoveries have described phage genes that inhibit CRISPR-Cas function. More than 20 protein families, previously of unknown function, have been ascribed anti-CRISPR function. Here, we discuss how these CRISPR-Cas inhibitors were discovered and their modes of action were elucidated. We also consider the potential impact of anti-CRISPRs on bacterial and phage evolution. Finally, we speculate about the future of this field.Entities:
Keywords: CRISPR-Cas; Cas9; anti-CRISPR; bacteriophage
Mesh:
Substances:
Year: 2017 PMID: 28749735 PMCID: PMC6039114 DOI: 10.1146/annurev-virology-101416-041616
Source DB: PubMed Journal: Annu Rev Virol ISSN: 2327-056X Impact factor: 10.431